Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2Thoracic 1Breast 1

Conditions

Thymus Neoplasms 1Solid Tumor 1Mesothelioma 1Lung Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Specimen Handling 641pembrolizumab 585Magnetic Resonance Spectroscopy 555Carboplatin 431Cyclophosphamide 381Cisplatin 379Biopsy 376Nivolumab 315Paclitaxel 314Gemcitabine 308Radiotherapy 286Bevacizumab 235Dexamethasone 218fludarabine 206Docetaxel 194durvalumab 189Oxaliplatin 189venetoclax 187Rituximab 175Fluorouracil 175atezolizumab 172Pemetrexed 167Capecitabine 164Radiosurgery 162Doxorubicin 162Radiation 160Ipilimumab 146Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Histocompatibility Testing × 90 days × Clear all
NCT07023822 2026-05-05

WISH, Feasibility of a Factorial Design

The University of Tennessee, Knoxville

Phase NA Completed
18 enrolled
Breast

Breast Neoplasms

NCT06895681 2026-05-04

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

University of California, San Francisco

Not yet recruiting
50,000 enrolled
Other solid neoplasm

Solid Tumor

NCT06996249 2026-03-03

DuTOC

Dutch Society of Physicians for Pulmonology and Tuberculosis

Recruiting
12,000 enrolled
Other solid neoplasmThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡